CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

The Wall Street JournalView source article

Part of story

McKesson and CD&R to acquire Option Care Health for $5.8 billion

Drug distributor McKesson and private equity firm Clayton, Dubilier & Rice agreed to take infusion therapy provider Option Care Health private in a deal valued at approximately $5.8 billion including debt.

Oct 6, 20264 sources

McKesson and CD&R to acquire Option Care Health for $5.8 billion

Other sources for this story

Reuters

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal | Reuters

Axios

McKesson and CD&R to acquire Option Care Health

Bloomberg

CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

Part of story

McKesson and CD&R to acquire Option Care Health for $5.8 billion

Other sources for this story

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal | Reuters

McKesson and CD&R to acquire Option Care Health

McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal

CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

Part of story

McKesson and CD&R to acquire Option Care Health for $5.8 billion

Other sources for this story

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal | Reuters

McKesson and CD&R to acquire Option Care Health

McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal